TickerFacts.

A business in context

JANX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-338078

  2. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-337977 · Items 2.02,9.01

  3. 4 · Ownership change

    Report date 2026-07-31 · 0001864158-26-000006

  4. 4 · Ownership change

    Report date 2026-07-08 · 0001864158-26-000004

  5. 8-K · Current report

    Report date 2026-06-23 · 0001193125-26-279428 · Items 8.01

  6. 4 · Ownership change

    Report date 2026-06-11 · 0001863094-26-000002

  7. 4 · Ownership change

    Report date 2026-06-11 · 0001780547-26-000004

  8. 4 · Ownership change

    Report date 2026-06-11 · 0001666963-26-000003

  9. 4 · Ownership change

    Report date 2026-06-11 · 0001326330-26-000002

  10. 4 · Ownership change

    Report date 2026-06-11 · 0001248190-26-000002

  11. 4 · Ownership change

    Report date 2026-06-11 · 0001231919-26-000631

  12. 8-K · Current report

    Report date 2026-06-11 · 0001193125-26-269387 · Items 5.07

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-212146

  14. 8-K · Current report

    Report date 2026-05-07 · 0001193125-26-211964 · Items 2.02,9.01

  15. 8-K · Current report

    Report date 2026-04-28 · 0001193125-26-187641 · Items 5.02

  16. DEF 14A · Proxy statement

    Report date 2026-06-11 · 0001193125-26-187095

  17. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-076918

  18. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-076627 · Items 2.02,9.01

  19. 8-K · Current report

    Report date 2026-01-21 · 0001193125-26-019520 · Items 1.01,7.01,9.01

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-269799

  21. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-269518 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2025-09-18 · 0001193125-25-209259 · Items 5.02

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-105069

  24. 8-K · Current report

    Report date 2025-08-07 · 0000950170-25-105010 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-06-11 · 0000950170-25-086284 · Items 5.07

  26. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-067083

  27. 8-K · Current report

    Report date 2025-05-08 · 0000950170-25-066969 · Items 2.02,9.01

  28. DEF 14A · Proxy statement

    Report date 2025-04-25 · 0000950170-25-058806

  29. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-029177

  30. 8-K · Current report

    Report date 2025-02-27 · 0000950170-25-029165 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2024-12-04 · 0001193125-24-271578 · Items 8.01,9.01

  32. 8-K · Current report

    Report date 2024-12-02 · 0000950170-24-132302 · Items 7.01,8.01,9.01

  33. SC 13G/A · Ownership disclosure

    0001193125-24-258521

  34. SC 13G/A · Ownership disclosure

    0001104659-24-118952

  35. SC 13G/A · Ownership disclosure

    0000921895-24-002714

  36. SC 13G/A · Ownership disclosure

    0000315066-24-002789

  37. SC 13D/A · Ownership disclosure

    0001104659-24-116001

  38. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-122370

  39. 8-K · Current report

    Report date 2024-11-06 · 0000950170-24-122279 · Items 2.02,9.01

  40. SC 13G/A · Ownership disclosure

    0001193125-24-250609

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 2 transaction rows2MTax / exercise payment: 0 transaction rows0FGift: 1 transaction rows1G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

3 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-07-31
2026-07-31
Campbell David AlanG · Gift
Disposed
Common Stock123840.00.0
2026-07-08
2026-07-10
Campbell David AlanM · Exercise / conversion
Acquired
Common Stock7000.04.21
2026-07-08
2026-07-10
Campbell David AlanM · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
7000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001817713Janux Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$10.59M$11.37M
    2023-12-31$8.08M$8.94M
    2022-12-31$8.61M$9.91M
    2021-12-31$3.64M$4.52M
    2020-12-31$0$0

    Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

    Explore the CPI history ↗